Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Dissecting the Therapeutic Mechanism of an Effective Combination Treatment Targeting Neuromuscular Junction Dengeneration and Myosteatosis to Combat Sarcopenia
Authors not listed
Chinese University of Hong Kong · 2023
Abstract
The investigators' pre-clinical study confirms the positive effects of combined treatment (VT + HMB) on reducing fat-to-lean tissue ratio, intramuscular fat infiltration and increasing muscle strength in sarcopenia animal model. The results showed that fat mass could be decreased by \~32%, while histology Oil Red O staining indicated a decrease of fat by almost 60%; in contrast, lean muscle mass increased by \~14%. On muscle strength, combined treatment increased twitch force, tetanic force and grip strength by \~30-66%. These in vivo results are very encouraging and the investigators should explore its potential in clinical translation. As VT and HMB supplement have been commercially available and their compliance rates are satisfactory, they can be translated to clinical application easily. The investigators' next step is to confirm its clinical efficacy, so that sarcopenia becomes a new indication of VT and HMB. The hypothesis is that combined treatment of VT and HMB can retard the progression of sarcopenia in human, in terms of muscle mass, muscle strength and performance.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-03 MST
Cite this
APA
Anonymous. (2023). Dissecting the Therapeutic Mechanism of an Effective Combination Treatment Targeting Neuromuscular Junction Dengeneration and Myosteatosis to Combat Sarcopenia. <em>Chinese University of Hong Kong</em>. https://clinicaltrials.gov/study/NCT05525039
Vancouver
Anonymous. Dissecting the Therapeutic Mechanism of an Effective Combination Treatment Targeting Neuromuscular Junction Dengeneration and Myosteatosis to Combat Sarcopenia. Chinese University of Hong Kong. 2023.
BibTeX
@misc{anon2023Dissec,
title = {Dissecting the Therapeutic Mechanism of an Effective Combination Treatment Targeting Neuromuscular Junction Dengeneration and Myosteatosis to Combat Sarcopenia},
author = {Anonymous},
journal = {Chinese University of Hong Kong},
year = {2023},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
The World Journal of Men s Health 2018
Open access · CC-BY
Testosterone and Sarcopenia
Journal of Diabetes Research 2020
Open access · CC-BY
Metabolic and Nutritional Characteristics in Middle-Aged and Elderly Sarcopenia Patients with Type 2 Diabetes
Baltimore VA Medical Center 2021
Open access · US-GOV
Increasing Muscle Capillarization to Enhance Responses to Strength Training in Sarcopenia
Abbott Nutrition 2014
Open access · US-GOV
Muscle Mass and Function in Chinese Adults
Frontiers in Pharmacology 2025
Open access · CC-BY
Deciphering the role of IGFBP5 in delaying fibrosis and sarcopenia in aging skeletal muscle: therapeutic implications and molecular mechanisms
The American Journal of Medicine 2006
Citation only